Quality of life during formoterol treatment: Comparison between asthma-specific and generic questionnaires

European Respiratory Journal

Volumn 12, Issue 1, 1998, Pages 30-34

  Van Der Molen, T ^a,d   Sears, M R ^b   De Graafft, C S ^c   Postma, D S ^a   Meyboom de Jong, B ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b MCMASTER UNIVERSITY   (Canada)

^c Location Alkmaar   (Netherlands)

^d NONE   (Netherlands)

Author keywords

agonists; Asthma; Formoterol; Quality of life

Indexed keywords

CORTICOSTEROID; FORMOTEROL; PLACEBO; TERBUTALINE;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ASTHMA; BRONCHODILATOR AGENTS; ETHANOLAMINES; FORCED EXPIRATORY VOLUME; HUMANS; PEAK EXPIRATORY FLOW RATE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0031816646     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12010030     Document Type: Article

References (24)

1. Guyatt GH, Veldhuyzen Van Zanten SJO, Feeny DH, Patric DL. Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J 1989; 140: 1441-1448.
2. Hyland ME, Kenyon CAP, Jacobs PA. Sensitivity of quality of life domains and constructs to longitudinal change in a clinical trial comparing salmeterol with placebo in asthmatics. Qual Life Res 1994; 3: 121-126.
3. Noonan M, Chervinsky P, Busse WW, et al. Fluticasone propionate reduces oral prednisolone use while it improves asthma control and quality of life. Am J Respir Crit Care Med 1995; 152: 1467-1473.
4. Maill AR, Kaptein AA, de Haes JCJM, Everaerd WThAM. Assessing quality of life in chronic non-specific lung disease: a review of empirical studies published between 1980 and 1994. Qual Life Res 1996; 5: 287-301.
5. Corsico R, Patruno V, Fracchia C. Anti-asthma drugs and quality of life. Eur Respir Rev 1993; 14: 366-368.
6. Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of guided self-management and traditional treatment of asthma over one year. Br Med J 1996; 312: 748-752.
7. Greening AP, Ind PW, Northfield M, Shaw G, Allen & Hanburys Ltd UK Study Group. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219-224.
8. Arvidsson P, Larsson S, Löfdahl CG, Melander B, Svedmyr N, Wåhlander L. Inhaled formoterol during one year in asthma: a comparison with salbutamol. Eur Respir J 1991; 4: 1168-1173.
9. Kesten S, Chapman KR, Broder I, et al. Sustained improvement in asthma with long term use of formoterol fumerate. Ann Allergy 1992; 69: 415-420.
10. Kesten S, Chapman KR, Broder I, et al. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis 1991; 144: 622-625.
11. Pearlman DS, Chervinsky P, LaForce C, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992; 327: 1420-1425.
12. Rowe BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis 1993; 148: 675-681.
13. van der Molen T, Postma DS, Turner MO, et al. Effects of the long-acting β-agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. Thorax 1997; 52: 535-539.
14. van der Molen T, Postma DS, Schreurs AJM, Bosveld HEP, Sears MR, Meyboom de Jong B. Discriminative aspects of two generic and two asthma specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma. Qual Life Res 1997; 6: 353-361.
15. Ware JE, Sherbourne CD. The MOS-36-item Short-form Health Status Survey(SF-36): 1. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
16. Ware JE, Kosinski M, Bayliss MS, McHorny CA, Rogers WH, Raczec A. Comparison of methods for the scoring and statistical analysis of SF36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 1995; 33: 264-279.
17. Kamman R, Flett R. A scale to measure current level of general happiness. Aust J Psychol 1983; 35: 259-265.
18. Wan TTH, Liviratos B. Interpreting a general index of subjective well-being. Milbank Mem Fund 1978; 56: 531-556.
19. Hyland ME, Finnis S, Irvine SH. A scale for assessing quality of life in adult asthma sufferers. J Psychosom Res 1991; 35: 99-110.
20. Hyland ME. The living with asthma questionnaire. Respir Med 1991; 85: 13-16.
21. Kaptein AA, Brand PLP, Dekker FW, et al. Quality-of-live in a long-term multicentre trial in chronic non-speciffc lung disease: assessment at baseline. Eur Respir J 1993; 6: 1479-1484.
22. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76-83.
23. Rutten-van Mölken MPMH, Custers F, Van Doorslaar EKA, et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur J Respir Dis 1995; 8: 888-898.
24. Hyland ME, Crocker GR. Validation of an asthma quality of life diary in a clinical trial. Thorax 1995; 50: 724-730.